Craft

Immusoft

Total Funding

$9.4 M

Immusoft Summary

Company Summary

Overview
Immusoft is a biotechnology company that develops therapies. It utilizes immune system programming (ISP) by programming B cells to produce therapeutic proteins for rare diseases.
Type
Private
Status
Active
Founded
2009
HQ
Seattle, WA, US | view all locations
Website
https://www.immusoft.com
Cybersecurity rating
Sectors

Key People

  • Sean Ainsworth

    Sean Ainsworth, Chief Executive Officer, Chairman of the Board

    • Wendell King

      Wendell King, Board Member

      • Matthew Scholz

        Matthew Scholz, Founder, Board Member

      • Rob Hayes

        Rob Hayes, Chief Scientific Officer

      LocationsView all

      2 locations detected

      • Seattle, WA HQ

        United States

        454 N 34th Street

      • San Francisco, CA

        United States

        1700 Owens Street, Unit B

      Footer menu